dehydroepiandrosterone sulfate has been researched along with pulmicort in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ebeling, PR; Erbas, B; Hopper, JL; Rubinfeld, AR; Wark, JD | 1 |
Kannisto, S; Korppi, M; Remes, K; Voutilainen, R | 1 |
Kannisto, S; Laatikainen, A; Savolainen, K; Taivainen, A; Tukiainen, H; Voutilainen, R | 1 |
3 trial(s) available for dehydroepiandrosterone sulfate and pulmicort
Article | Year |
---|---|
Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids.
Topics: Absorptiometry, Photon; Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Beclomethasone; Biomarkers; Bone Density; Budesonide; Dehydroepiandrosterone Sulfate; Female; Femur; Glucocorticoids; Humans; Hydrocortisone; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Ribs | 1998 |
Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression in asthmatic children treated with inhaled steroids.
Topics: Administration, Inhalation; Adrenocorticotropic Hormone; Androstadienes; Asthma; Budesonide; Child; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Female; Fluticasone; Humans; Male | 2001 |
Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients.
Topics: Administration, Inhalation; Adrenal Cortex; Adult; Aged; Asthma; Bronchodilator Agents; Budesonide; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hydrocortisone; Male; Middle Aged; Osmolar Concentration | 2004 |
1 other study(ies) available for dehydroepiandrosterone sulfate and pulmicort
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |